FDA Says One-Dose Johnson & Johnson COVID-19 Vaccine Is Safe, Effective | Eastern North Carolina Now

Publisher's Note: This post appears here courtesy of the The Daily Wire. The author of this post is Charlotte Pence Bond.

    The Food and Drug Administration (FDA) on Wednesday released its analysis of Johnson & Johnson's one-shot dose COVID-19 vaccine, supporting its authorization for emergency use.

    The vaccine would be the third to become available in the United States, after the Pfizer-BioNTech vaccine and the Moderna vaccine were approved. A panel of advisers to the FDA will reportedly meet on Friday in order to evaluate the vaccine and make their recommendation on whether it should be given the green light.

    The FDA's analysis found that the Johnson & Johnson vaccine has "a favorable safety profile with no specific safety concerns identified that would preclude issuance of an EUA [Emergency Use Authorization]." This language is similar to the assessments for the Moderna and Pfizer-BioNTech vaccines, according to NPR.

    Immunization requires only one shot, which is different from the current vaccines from Pfizer and Moderna that are being distributed in the United States, which are composed of two shots. It also doesn't need unique refrigeration for its transportation and storage.

    Its efficacy in preventing COVID-19, however, is lower than the other two vaccines. The FDA review reportedly pointed to an international study that was conducted with about 40,000 people — half receiving the placebo, half the vaccine. The study showed the Johnson & Johnson vaccine was 66% effective in preventing moderate to severe COVID-19. This particular study was done in the U.S., Latin America, and South Africa.

    The Pfizer and Moderna vaccines report an efficacy rate of 95% and 94%, respectively.

    NPR reports that though the new variants of the coronavirus in South Africa and Brazil, "where the Johnson & Johnson vaccine was tested, mutated in ways that help them evade the immune response prompted by vaccines developed against the original form of the virus," the vaccine's effect is still promising.

    Dr. Ashish Jha, the dean of the Brown University School of Health, spoke to NPR's "All Things Considered" on Monday.

    NPR reported:

  • "What you care about is hospitalizations and deaths," he said. In the large clinical trial that is the centerpiece of the company's application to the FDA, nobody who received the vaccine required hospitalization or died once the vaccine took full effect (28 days after immunization). "Johnson & Johnson appears to be just as good as Moderna and Pfizer at preventing those," Jha said.
  • The most common adverse reactions among more than 6,000 study participants who were queried about their experience were injection site pain (49%), headache (39%), fatigue (38%) and muscle pain (33%). These side effects were mostly mild or moderate.

    The authorization of a third vaccine could help more Americans get vaccinated, expanding the supply of effective doses. NPR noted it won't immediately make a big difference, however.

    A Johnson & Johnson executive spoke at a congressional hearing Tuesday, saying that 4 million doses of vaccine would be available in the U.S. when the FDA grants an emergency use authorization. A total of 20 million doses would be ready by the end of March, he said, and the company could deliver a total of 100 million doses by the end of June.
Go Back


Leave a Guest Comment

Your Name or Alias
Your Email Address ( your email address will not be published)
Enter Your Comment ( no code or urls allowed, text only please )




Judicial Watch to Facebook: End Censorship of Trump Guest Editorial, Editorials, Op-Ed & Politics Boebert Takes on Pork Barrel Spending


HbAD0

Latest Op-Ed & Politics

Like many other states, the North Carolina has received a lot of money from the federal government to address the impacts of the corona virus pandemic.
A local wife began training to join her regional women's hockey team when she discovered the grand prize for winners of the National Hockey League is a Stanley Cup.
it is time to prosecture them for election interference
A Chinese national was detained by Immigration and Customs Enforcement after the bust of a massive marijuana operation in rural south Georgia last week.
Felon voting advocates argue in a new court filing that North Carolina's new election law should have no impact on their federal lawsuit.
That is one that was stopped how many weren't stopped
The game show “Jeopardy!,” in which gives contestants must give answers in the form of a question, embraced the woke agenda by including so-called “neo-pronouns” as an answer.

HbAD1

City employing all-of-government effort aimed at finding work for illegal immigrants, emails indicate
Embattled former New York Congressman George Santos has landed on his feet following his ouster from the U.S. House of Representatives, with the announcement that he has been hired as a fact-checker at The New York Times.
Former President Donald Trump won Michigan’s Republican Party presidential primary on Tuesday night, beating former U.N. Ambassador Nikki Haley by more than 30 points.
New York City Democrat Mayor Eric Adams said this week that illegal alien crime in the city is getting so bad, officials need to look at modifying the city’s sanctuary status so that local law enforcement can cooperate with federal immigration officials to deport violent criminals.
On Thursday, Nov. 2, a group of protesters blocked the Durham Freeway (NC-147), the main artery through Durham and a major connector for the Research Triangle area, during rush hour.
The Tennessee state House passed a bill on Monday that would prohibit the flying of any flag other than the American flag and a few other official flags in public school classrooms, legislation that was sparked by the prevalence of pride flags in recent years.
The Democrat Party remains fractured under Joe Biden. In recent days, the embarrassments of Super Tuesday have continued.

HbAD2

 
Back to Top